Maaisha Osman

4 days ago | insidehealthpolicy.com | Maaisha Osman

HHS is preparing to launch one of the largest public awareness advertising campaigns in its history to encourage Americans to use wearable health devices -- such as continuous glucose monitors (CGMs) -- in a push to improve public health outcomes through technology.

1 week ago | insidehealthpolicy.com | Maaisha Osman

The Senate health committee will hold a confirmation hearing next week for Susan Monarez, the Trump administration’s nominee to lead the Centers for Disease Control and Prevention (CDC), as public health experts are calling on stakeholders to prepare for a future where traditional public health advisory bodies, like the CDC’s Advisory Committee on Immunization Practices (ACIP), are no longer relied upon.

1 week ago | insidehealthpolicy.com | Maaisha Osman

FDA will begin a new voucher program that will allow sponsors who “support U.S. national interests” to access a pilot program for significantly expedited drug review, the agency announced Tuesday (June 17), in a first-of-its-kind program not authorized by Congress.

2 weeks ago | insidehealthpolicy.com | Maaisha Osman

A draft drug pricing bill floated by Sen. Bill Cassidy (LA) that would penalize manufacturers that offer lower prices overseas is facing resistance on Capitol Hill and is unlikely to be included in the Senate’s fast-moving reconciliation package, an industry lobbyist tells Inside Health Policy.

2 weeks ago | insidehealthpolicy.com | Maaisha Osman

HHS Secretary Robert F. Kennedy Jr. promised unbiased experts free of conflicts of interest would replace the members of the Advisory Committee on Immunization Practices (ACIP) he dismissed, but two of the newly tapped vaccine advisers have served as paid expert witnesses in lawsuits targeting major vaccine makers -- a role experts allege poses a glaring conflict of interest for members of the Centers for Disease Control and Prevention’s (CDC’s) top vaccine advisory panel.